Does TOCILIZUMAB Cause Central nervous system lesion? 25 Reports in FDA Database

Q: Does TOCILIZUMAB cause Central nervous system lesion?

25 reports of Central nervous system lesion have been filed with the FDA for TOCILIZUMAB, representing 0.0% of all TOCILIZUMAB adverse event reports.

Q: How dangerous is Central nervous system lesion from TOCILIZUMAB?

Of 25 reports, 2 (8.0%) resulted in death and 10 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Central nervous system lesion have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.0% of all adverse event reports for TOCILIZUMAB.

Reports of Central nervous system lesion with TOCILIZUMAB

0.0%

of all TOCILIZUMAB reports

Deaths

Hospitalizations

How Dangerous Is Central nervous system lesion From TOCILIZUMAB?

Of the 25 reports, 2 (8.0%) resulted in death, 10 (40.0%) required hospitalization, and 2 (8.0%) were considered life-threatening.

Is Central nervous system lesion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 25 reports have been filed with the FAERS database.

What Other Side Effects Does TOCILIZUMAB Cause?

Drug ineffective (32,342) Rheumatoid arthritis (20,652) Pain (18,384) Off label use (18,256) Arthralgia (15,536) Joint swelling (14,831) Fatigue (13,802)